|
🐜
|
A Role for miR-145 in Pulmonary Arterial Hypertension: Evidence From Mouse Models and Patient Samples
17 auth.
P. Caruso,
Y. Dempsie,
Hannah C. Stevens,
R. Mcdonald,
L. Long,
Ruifang Lu,
Kevin P. White,
K. Mair,
J. McClure,
M. Southwood,
...
P. Upton,
Mei Xin,
E. van Rooij,
E. Olson,
N. Morrell,
M. MacLean,
A. Baker
|
8 |
2012 |
8
🐜
|
|
🐜
|
Activity of the Estrogen-Metabolizing Enzyme Cytochrome P450 1B1 Influences the Development of Pulmonary Arterial Hypertension
13 auth.
Kevin P. White,
A. K. Johansen,
M. Nilsen,
L. Ciuclan,
Emma Wallace,
L. Paton,
Annabel Campbell,
I. Morecroft,
Lynn Loughlin,
J. McClure,
...
Matthew J. Thomas,
K. Mair,
M. MacLean
|
7 |
2012 |
7
🐜
|
|
🦁
|
Sex-dependent influence of endogenous estrogen in pulmonary hypertension.
11 auth.
K. Mair,
Audrey F. Wright,
Nicholas Duggan,
D. Rowlands,
M. Hussey,
Sonia Roberts,
...
J. Fullerton,
M. Nilsen,
Lynn Loughlin,
Matthew J. Thomas,
M. MacLean
|
7 |
2014 |
7
🦁
|
|
🦁
|
Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response
K. Mair,
Anne Katrine Johansen,
Audrey F. Wright,
Emma Wallace,
Margaret R. MacLean
|
6 |
2014 |
6
🦁
|
|
🐜
|
Development of pulmonary arterial hypertension in mice over-expressing S100A4/Mts1 is specific to females
8 auth.
Y. Dempsie,
M. Nilsen,
Kevin P. White,
K. Mair,
Lynn Loughlin,
N. Ambartsumian,
...
M. Rabinovitch,
M. MacLean
|
6 |
2011 |
6
🐜
|
|
🐜
|
Sphingosine Kinase 1 Induces Tolerance to Human Epidermal Growth Factor Receptor 2 and Prevents Formation of a Migratory Phenotype in Response to Sphingosine 1-Phosphate in Estrogen Receptor-Positive Breast Cancer Cells
9 auth.
J. Long,
J. Edwards,
C. Watson,
S. Tovey,
K. Mair,
R. Schiff,
...
V. Natarajan,
N. Pyne,
S. Pyne
|
6 |
2010 |
6
🐜
|
|
🦁
|
Sex affects bone morphogenetic protein type II receptor signaling in pulmonary artery smooth muscle cells.
9 auth.
K. Mair,
Xudong Yang,
L. Long,
Kevin P. White,
Emma Wallace,
M. Ewart,
...
C. Docherty,
N. Morrell,
M. MacLean
|
6 |
2015 |
6
🦁
|
|
🦁
|
Obesity, estrogens and adipose tissue dysfunction – implications for pulmonary arterial hypertension
K. Mair,
R. Gaw,
M. MacLean
|
6 |
2020 |
6
🦁
|
|
🐜
|
Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension
9 auth.
Y. Dempsie,
N. Macritchie,
Kevin P. White,
I. Morecroft,
Audrey F. Wright,
M. Nilsen,
...
Lynn Loughlin,
K. Mair,
M. MacLean
|
6 |
2013 |
6
🐜
|
|
🐜
|
A Sex-Specific MicroRNA-96/5-Hydroxytryptamine 1B Axis Influences Development of Pulmonary Hypertension.
10 auth.
Emma Wallace,
N. Morrell,
Xudong Yang,
L. Long,
Hannah C. Stevens,
M. Nilsen,
...
Lynn Loughlin,
K. Mair,
A. Baker,
M. MacLean
|
6 |
2015 |
6
🐜
|
